Jam

ETHZilla (formerly 180 Life Sciences) closed a $425 million private placement to advance its Ethereum treasury strategy. The company plans to rapidly increase its ETH holdings and execute a differentiated yield generation program in partnership with Electric Capital and with guidance from a new DeFi Council. ETHZilla aims to become a benchmark for on-chain treasury management, offering investors exposure to the Ethereum network. The capital will also support existing iGaming operations and IP monetization. The executive team and board have been expanded with crypto and capital markets expertise.

Praxis Precision Medicines (PRAX) CEO Marcio Souza will participate in a virtual fireside chat hosted by Truist Securities analyst Joon Lee on August 5, 2025, at 10:00 AM EST. The company focuses on developing therapies for central nervous system (CNS) disorders, specifically targeting neuronal excitation-inhibition imbalance using their Cerebrum™ and Solidus™ platforms. Praxis has a diversified CNS portfolio with four product candidates in clinical development.

Pacific Green Technologies (PGTK) secured a 10-year agreement with ZEN Energy for 1.5GWh of battery storage across three Australian states. This expands PGTK’s Australian project portfolio to 7GWh, building on an existing 500MWh agreement. The partnership aims to support ZEN’s commercial and industrial clients and manage energy transition volatility. CEO’s from Pacific Green and Zen highlight the strategic importance of storage and the partnership’s role in enabling them to support sustainability goals.

New Mountain Finance Corporation (NMFC) reported Q2 2025 net investment income of $0.32 per share and declared a Q3 distribution of $0.32 per share. The net asset value was $12.21 per share, down from $12.45 in the previous quarter. Approximately 95% of the portfolio is internally rated green. NMFC increased its senior-oriented asset mix to 78% and repurchased $9.6 million of shares. The company also received a third SBIC license. The investment portfolio stood at $3,014.2 million across 124 companies.

Magnera Corporation (NYSE: MAGN) will participate in the 2025 UBS Global Materials Conference in New York City on September 3, 2025. CEO Curt Begle, CFO Jim Till, and EVP Robert Weilminster will engage with investors through one-on-one consultations and small group meetings. Magnera is a materials solutions provider serving over 1,000 customers globally with a diverse portfolio including components for hygiene products, building and construction, and the food & beverage industry. The company operates 46 global production facilities and employs over 9,000 people.

Optex Systems Holdings (OPXS) will release its fiscal 2025 third-quarter financial results on August 12, 2025, followed by an earnings conference call. The company, a manufacturer of precision optical sighting systems for military and commercial applications, will make the earnings release available on its investor relations website. Optex’s products are used in U.S. military vehicles and also include periscopes and rifle sights.

Mainz Biomed (MYNZ) has priced a $3.0 million follow-on offering at $1.35 per unit, consisting of 2,222,222 units. Each unit includes one ordinary share (or pre-funded warrant) and one Series A warrant exercisable at $1.35, expiring in five years. Maxim Group LLC is the sole placement agent. The offering is expected to close around August 5, 2025, subject to customary conditions. The offering provides minimal capital and potential shareholder dilution.

Foresight Autonomous Holdings secured I4F approval and $5 million in funding for a joint drone development project with Big Bang Boom Solutions, commencing September 2025. The 24-month project aims to create autonomous industrial inspection drones with visible-light and thermal sensors for GPS-denied environments. Big Bang projects potential revenue of $32 million by 2031, targeting industries driving the drone inspection market, expected to reach $21.3 billion by 2027. The ruggedized drones will enhance safety and efficiency in sectors like oil & gas and mining.

SiriusPoint (SPNT) reported strong Q2 2025 results with a Core combined ratio of 89.5%, a 3.8-point year-over-year improvement. Core underwriting income soared 83% to $68 million. Net income was $59.2 million ($0.50 per diluted share), and gross premiums written grew 10%. The return on equity reached 12.7%, with an underlying ROE of 17.0%, exceeding the target range. Book value per diluted share (ex. AOCI) increased 3.2% to $15.64, and the Q2’25 BSCR estimate is 223%.

CrowdStrike’s 2025 report reveals that adversaries are weaponizing GenAI to scale attacks, targeting AI agents and autonomous systems. DPRK-linked hackers infiltrated over 320 companies using GenAI. Cybercriminals are exploiting AI agent vulnerabilities to steal credentials and deploy malware. Cloud attacks, especially from Chinese groups, surged by 136%. The report emphasizes securing AI systems against these emerging threats as the cyber battleground evolves.